LigaChem Biosciences Inc. (KOSDAQ:141080)
171,700
+4,700 (2.81%)
Dec 19, 2025, 3:30 PM KST
LigaChem Biosciences Market Cap
LigaChem Biosciences has a market cap or net worth of 6.08 trillion as of December 19, 2025. Its market cap has increased by 74.56% in one year.
Market Cap
6.08T
Enterprise Value
5.54T
Revenue
159.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
171,700.00
Market Cap Chart
Since May 10, 2013, LigaChem Biosciences's market cap has increased from 101.00B to 6.08T, an increase of 5,919.65%. That is a compound annual growth rate of 38.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 6.25T | 57.24% |
| Dec 30, 2024 | 3.98T | 117.55% |
| Dec 28, 2023 | 1.83T | 67.21% |
| Dec 29, 2022 | 1.09T | -19.19% |
| Dec 30, 2021 | 1.35T | -18.55% |
| Dec 30, 2020 | 1.66T | 193.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.45T |
| Celltrion | 39.93T |
| ALTEOGEN | 22.52T |
| SK Biopharmaceuticals | 10.26T |
| ABL Bio | 10.04T |
| Yuhan | 8.53T |
| HLB Co., Ltd. | 6.05T |
| Peptron | 5.68T |